Literature DB >> 7479922

Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

A L Kinter1, S M Bende, E C Hardy, R Jackson, A S Fauci.   

Abstract

The nonlytic suppression of human immunodeficiency virus (HIV) production from infected CD4+ T cells by CD8+ lymphocytes from HIV-infected individuals is one of the most potent host-mediated antiviral activities observed in vitro. We demonstrate that the pleiotropic cytokine interleukin 2 (IL-2), but not IL-12, is a potent inducer of the CD8+ HIV suppressor phenomenon. IL-2 induces HIV expression in peripheral blood or lymph node mononuclear cells from HIV-infected individuals in the absence of CD8+ T cells. However, IL-2 induces CD8+ T cells to suppress HIV expression when added back to these cultures, and this effect dramatically supersedes the ability to IL-2 to induce HIV expression. Five to 25 times fewer CD8+ cells were required to obtain comparable levels of inhibition of viral production if they were activated in the presence of IL-2 as compared with IL-12 or no exogenous cytokine. Furthermore, IL-2 appeared either to induce a qualitative increase in HIV suppressor cell activity or to increase the relative frequency of suppressor cells in the activated (CD25+) CD8+ populations. Analyses of proviral levels in peripheral blood mononuclear cells suggest that CD8+ T cell-mediated lysis of in vivo infected cells is not induced by IL-2. These results have implications for our understanding of the effects of impaired IL-2 production during HIV disease as well as the overall effects of IL-2-based immunotherapy on HIV replication in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479922      PMCID: PMC40555          DOI: 10.1073/pnas.92.24.10985

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.

Authors:  B Perussia; S H Chan; A D'Andrea; K Tsuji; D Santoli; M Pospisil; D Young; S F Wolf; G Trinchieri
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.

Authors:  A M Gómez; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Cytokine patterns during the progression to AIDS.

Authors:  T R Mosmann
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

Review 4.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

Authors:  G Trinchieri
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

Review 5.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

Review 6.  The IL-2/IL-2 receptor system: a target for rational immune intervention.

Authors:  T A Waldmann
Journal:  Immunol Today       Date:  1993-06

7.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

8.  CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.

Authors:  C H Chen; K J Weinhold; J A Bartlett; D P Bolognesi; M L Greenberg
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

9.  Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor.

Authors:  C E Mackewicz; H Ortega; J A Levy
Journal:  Cell Immunol       Date:  1994-02       Impact factor: 4.868

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  20 in total

1.  Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression.

Authors:  A H Patki; M E Quiñones-Mateu; D Dorazio; B Yen-Lieberman; W H Boom; E K Thomas; M M Lederman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.

Authors:  Anita Parmigiani; Maria F Pallin; Helena Schmidtmayerova; Mathias G Lichtenheld; Savita Pahwa
Journal:  Hum Immunol       Date:  2010-10-25       Impact factor: 2.850

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

4.  Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Authors:  L Al-Harthi; K A Roebuck; A Landay
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

5.  Characterization of the phenotypic and lymphokine profile associated with strong CD8+ anti-HIV-1 suppressor activity (CASA).

Authors:  J Wilkinson; J J Zaunders; A Carr; G Guillemin; D A Cooper
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 6.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

7.  Prolonged dominance of clonally restricted CD4(+) T cells in macaques infected with simian immunodeficiency viruses.

Authors:  Z W Chen; Y Shen; Z Kou; C Ibegbu; D Zhou; L Shen; P Morrison; C Bogle; H M McClure; A J Nahmias; P K Sehgal; N L Letvin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys.

Authors:  Alagarraju Muthukumar; Dejiang Zhou; Mirko Paiardini; Ashley P Barry; Kelly S Cole; Harold M McClure; Silvija I Staprans; Guido Silvestri; Donald L Sodora
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

Review 9.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

10.  Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells.

Authors:  David Verhoeven; Sumathi Sankaran; Melanie Silvey; Satya Dandekar
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.